| Frailty in older adults: evidence for a phenotype LP Fried, CM Tangen, J Walston, AB Newman, C Hirsch, J Gottdiener, ... The Journals of Gerontology Series A: Biological Sciences and Medical …, 2001 | 25101 | 2001 |
| Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease … TA Pearson, GA Mensah, RW Alexander, JL Anderson, RO Cannon III, ... circulation 107 (3), 499-511, 2003 | 8775 | 2003 |
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men PM Ridker, M Cushman, MJ Stampfer, RP Tracy, CH Hennekens New England journal of medicine 336 (14), 973-979, 1997 | 7868 | 1997 |
| Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) A Festa, R D’Agostino Jr, G Howard, L Mykkänen, RP Tracy, SM Haffner Circulation 102 (1), 42-47, 2000 | 3700 | 2000 |
| Coronary calcium as a predictor of coronary events in four racial or ethnic groups R Detrano, AD Guerci, JJ Carr, DE Bild, G Burke, AR Folsom, K Liu, ... New England Journal of Medicine 358 (13), 1336-1345, 2008 | 3146 | 2008 |
| Multi-ethnic study of atherosclerosis: objectives and design DE Bild, DA Bluemke, GL Burke, R Detrano, AV Diez Roux, AR Folsom, ... American journal of epidemiology 156 (9), 871-881, 2002 | 3091 | 2002 |
| Major lipids, apolipoproteins, and risk of vascular disease R Assessment Jama 302 (18), 1993-2000, 2009 | 3058 | 2009 |
| C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Emerging Risk Factors Collaboration The Lancet 375 (9709), 132-140, 2010 | 2751 | 2010 |
| The cardiovascular health study: design and rationale LP Fried, NO Borhani, P Enright, CD Furberg, JM Gardin, RA Kronmal, ... Annals of epidemiology 1 (3), 263-276, 1991 | 2740 | 1991 |
| Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly TB Harris, L Ferrucci, RP Tracy, MC Corti, S Wacholder, WH Ettinger Jr, ... The American journal of medicine 106 (5), 506-512, 1999 | 2057 | 1999 |
| Inflammation as a risk factor for atrial fibrillation RJ Aviles, DO Martin, C Apperson-Hansen, PL Houghtaling, P Rautaharju, ... Circulation 108 (24), 3006-3010, 2003 | 1949 | 2003 |
| Inflammatory and coagulation biomarkers and mortality in patients with HIV infection LH Kuller, R Tracy, W Belloso, SD Wit, F Drummond, HC Lane, ... PLoS medicine 5 (10), e203, 2008 | 1907 | 2008 |
| Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study MRFIT Research Group, LH Kuller, RP Tracy, J Shaten, EN Meilahn American journal of epidemiology 144 (6), 537-547, 1996 | 1680 | 1996 |
| Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis FS Collaboration Jama 294 (14), 1799-1809, 2005 | 1663 | 2005 |
| Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease PM Ridker, M Cushman, MJ Stampfer, RP Tracy, CH Hennekens Circulation 97 (5), 425-428, 1998 | 1609 | 1998 |
| Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study A Festa, R D’Agostino Jr, RP Tracy, SM Haffner Diabetes 51 (4), 1131-1137, 2002 | 1441 | 2002 |
| Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study MI Schmidt, BB Duncan, AR Sharrett, G Lindberg, PJ Savage, ... The Lancet 353 (9165), 1649-1652, 1999 | 1439 | 1999 |
| HIV infection and the risk of acute myocardial infarction MS Freiberg, CCH Chang, LH Kuller, M Skanderson, E Lowy, KL Kraemer, ... JAMA internal medicine 173 (8), 614-622, 2013 | 1431 | 2013 |
| Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program D Taliun, DN Harris, MD Kessler, J Carlson, ZA Szpiech, R Torres, ... Nature 590 (7845), 290-299, 2021 | 1316 | 2021 |
| Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial MM Redfield, HH Chen, BA Borlaug, MJ Semigran, KL Lee, G Lewis, ... Jama 309 (12), 1268-1277, 2013 | 1307 | 2013 |
